title: Lamivudine and HBV-associated nephropathy.
authors.forename: Hassane
authors.initials: H
authors.lastname: Izzedine
authors.forename: Julien
authors.initials: J
authors.lastname: Massard
authors.forename: Thierry
authors.initials: T
authors.lastname: Poynard
authors.forename: Gilbert
authors.initials: G
authors.lastname: Deray
mesh_terms: D002648:Child; D002675:Child, Preschool; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy* / Q000821:virology; D018347:Hepadnaviridae Infections / Q000188:drug therapy* / Q000821:virology; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine